PROPOFOL BAXTER 20 mg/ml, injectable emulsion/for infusion 10 bottles of 50 ml
Active ingredients: Propofol
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Emulsion for infusion10 bottles of 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROPOFOL BAXTER 20 mg/ml, émulsion injectable/pour perfusion
- Pharmaceutical form
- émulsion injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 50 ml
- Marketing authorisation holder
- BAXTER HOLDING (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Sept 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66093051CIP75500178CIP133400955001782Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPOFOLémulsion | 20 mg · 1 ml d'émulsion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.